Glaucoma is the Second Leading Cause of Blindness Worldwide.

Qdata® Can Help Advance Glaucoma Treatment.

Qdata Glaucoma is an exclusive dataset reflective of 5.2M+ de-identified US patients with curated glaucoma-specific outcome measures, such as intraocular pressure (IOP) and detailed procedure details.

About Qdata

Qdata® by Verana Health are research ready, fit-for-purpose data modules designed to confidently drive business insights and inform research outcomes. Qdata spans ophthalmology, neurology, and urology to help unlock quality insights across the entire drug and device development cycle.

animated magnifying glass icon

Exclusive Glaucoma Therapeutic Insights

Only found here from the IRIS Registry® (Intelligent Research in Sight)


High-quality Glaucoma Outcomes Data

Curated glaucoma-specific outcome measures for analysis, such as IOP

animated person atop arrow icon

Most Comprehensive View of Glaucoma Patient Journey

A deeper view into treatment details, including MIGS brands that share codes

Qdata_Glaucoma_Orange_4x (1)

By the Numbers


Total de-identified patients with glaucoma*


Patients with glaucoma who received MIGS procedures**


Average length of follow-up for glaucoma patients

eye looking into equipment with a band of light

*Includes patients starting in January of 2016 with 1+ day of open or closed medical or pharmacy claims at any time and 1 valid IOP reading in IRIS Registry. Data current to September 2023.

** Source: IRIS Registry; MIGS defined by CPT Codes and/or clinical notes

Meet with a Qdata Expert or Request a Data Count

Key Variables in Qdata Glaucoma

Curated variables are extracted from EHR data to be utilized based on your research needs.

IOP Readings

MIGS Device Brand

Visual Acuity Reading


Unstructured Data Enables Deeper Understanding

Verana Health applies clinician-informed algorithms to unstructured EHR data at scale to help extract key information on IOP, MIGS procedure details and more, which can then be analyzed across large populations in a reliable manner.

This can give life sciences companies unprecedented insights to better understand treatment patterns and outcomes, track adverse events, monitor market uptake, and more.


of Medical Data Remains Unstructured


Talk to a Qdata Expert

Take a minute to submit your contact information and one of our team members will reach out to you.